menu
    • menu

    Company profile for Napo Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are Napo Therapeutics: an European pharmaceutical company, a young start-up led by a team of experienced professionals. Our mission is to improve the quality of life of people suffering from rare diseases and pathologies with a strong unmet medical need through innovative solutions.Our research goal is to develop and commercialize new natural and sustainable prescription drugs for patients suffering from pathologies of the...
    We are Napo Therapeutics: an European pharmaceutical company, a young start-up led by a team of experienced professionals. Our mission is to improve the quality of life of people suffering from rare diseases and pathologies with a strong unmet medical need through innovative solutions.Our research goal is to develop and commercialize new natural and sustainable prescription drugs for patients suffering from pathologies of the gastrointestinal tract. We are initially focused specifically on chronic rare diseases of gastrointestinal malabsorption and excessive intestinal fluid output (e.g., short bowel syndrome).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Napo TherapeuticsItaly Flag
    Country
    Country
    Italy
    Address
    Address
    Via Michele Barozzi, 2 20122 Milano
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://napotherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Jaguar Health Updates Orphan Disease Intestinal Failure Program
    Jaguar Health Updates Orphan Disease Intestinal Failure Program

    23 Jun 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/jaguar-health-provides-updates-on-orphan-disease-intestinal-failure-d-1041607

    ACCESSWIRE
    23 Jun 2025
    Share Share
    Jaguar Health Announces $1.5M Direct Offering Under Nasdaq Rules
    Jaguar Health Announces $1.5M Direct Offering Under Nasdaq Rules

    21 May 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/jaguar-health-announces-1.5-million-registered-direct-offering-priced-1030213

    ACCESSWIRE
    21 May 2025
    Share Share
    Jaguar Starts Phase 2 Trial of Crofelemer for Pediatric MVID
    Jaguar Starts Phase 2 Trial of Crofelemer for Pediatric MVID

    20 May 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/first-patient-randomized-in-jaguar-healths-phase-2-randomized-double-1029830

    ACCESSWIRE
    20 May 2025
    Share Share
    Jaguar to Share Crofelemer Study Data in April 30 Webcast
    Jaguar to Share Crofelemer Study Data in April 30 Webcast

    29 Apr 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/reminder-jaguar-health-hosting-april-30-investor-webcast-to-present-i-1021431

    ACCESSWIRE
    29 Apr 2025
    Share Share
    Napo Therapeutics Named “Best Pharmaceuticals Innovator of Year”
    Napo Therapeutics Named “Best Pharmaceuticals Innovator of Year”

    19 Nov 2024

    // ACCESSWIRE

    https://www.accesswire.com/944037/jaguar-health-family-company-napo-therapeutics-named-best-pharmaceuticals-innovator-of-the-year-europe

    ACCESSWIRE
    19 Nov 2024
    Share Share
    Jaguar Health Strengthens IP With New Patents For SBS And CDD Treatments
    Jaguar Health Strengthens IP With New Patents For SBS And CDD Treatments

    08 Jul 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=884784&lang=en

    ACCESSWIRE
    08 Jul 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search